You're reading: France 24: Pfizer-BioNTech vaccine works against new UK, South African Covid-19 variants, study says

France 24: Pfizer-BioNTech vaccine works against new UK, South African Covid-19 variants, study says

Published Jan. 9, 2021 at 7:37 am

This picture shows a syringe and a dose of the Pfizer-BioNTech Covid-19 vaccine at the hospital Hotel-Dieu in Paris, on Jan. 2, 2021 as part of a vaccination campaign for healthcare workers aged 50 years and more.

Photo by AFP

German company BioNTech said Friday a preliminary study shows that its vaccine works against a key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than normal coronavirus strains.